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PURPOSE. To evaluate the impact of glaucoma on visual
functioning in Indians.
METHODS. Patients attending the glaucoma service who had
undergone a comprehensive glaucoma evaluation were recruit-
ed. Better mean deviation (MD, using Humphrey Field Analyzer
program 24-2) between two eyes was used to classify participants
into mild, moderate, and severe visual field (VF) loss groups.
Participants were administered the Glaucoma Quality of Life-15
(GQL-15) questionnaire. Rasch analysis was used to validate the
GQL-15 and its four subscales. Linear regression was used to
determine associations between GQL-15 scores and VF loss after
adjusting for sociodemographic variables.
RESULTS. A total of 198 patients (mean age 6 SD, 59.8 6 12.3
years; 67% male) were recruited. Participants with severe VF
loss (39%) followed by mild loss (35%) comprised the largest
group. Rasch analysis resulted in a 10-item reliable and valid
questionnaire: the Glaucoma Activity Limitation-10 (GAL-10).
Although a single subscale, ‘‘peripheral vision,’’ met require-
ments of the Rasch model, it could not be preserved in the
GAL-10. In multivariate analyses, the middle-income group
(compared with higher income) and severe VF-loss (compared
with mild VF-loss) participants reported significantly poorer
functioning on GAL-10 ([b ¼ 0.84; 95% confidence interval
(CI), 0.16–1.52; P¼0.02] and [b¼1.19; 95% CI, 0.61–1.78; P <
0.000], respectively). None of these associations were,
however, clinically significant.
CONCLUSIONS. Glaucoma patients in India, especially those with
severe VF loss, face significant challenges in performing daily
tasks and in mobility. It is important to prevent progression
such that activity limitation is minimized in glaucoma patients.
(Invest Ophthalmol Vis Sci. 2012;53:6081–6092) DOI:
10.1167/iovs.12-9885
Glaucoma is a progressive optic neuropathy that results inirreversible loss of the visual field (VF). It is the world’s
second leading cause of irreversible blindness.1–3 Recent
population-based studies from India have reported the
prevalence of glaucoma blindness in those aged 40 years and
older to range between 1.5% and 20% depending upon the
type of glaucoma and location of residence.4–10 Furthermore
increased prevalence from primary angle-closure glaucoma
(PACG) and those living in rural areas than primary open-angle
glaucoma (POAG) and those living in urban areas.4 Given the
increased risk of glaucoma with age (i.e., especially those over
40 years),1,5–7 there are serious economic and public health
concerns associated with this chronic disease.11
The impact of glaucoma on a person is wide ranging. Early
stages of the disease are characterized by a relatively intact
central VF, so the disease often goes unnoticed.9,10 By contrast,
progressive loss of the peripheral VF occurs with advancing
glaucoma, thereby resulting in difficulty in performing day-to-
day activities (i.e., activity limitation) that involve use of
peripheral vision or contrast, such as independent navigation,
reading, driving, and so forth.12 Given that clinical measure-
ments are made under controlled clinic conditions, they fail to
capture all the aspects of vision functioning that are important
from a patient’s perspective.13 The patient’s perception is,
therefore, as important as the extent of the disease in assessing
the severity of glaucoma.
Recently, two systematic reviews of the questionnaires used
to assess the impact of glaucoma from the patient’s perspective
have been published.14,15 The Glaucoma Quality of Life-15
(GQL-15) is one such questionnaire.16 It is glaucoma specific in
that it includes questions relevant to patients with glaucoma,
so it is intuitively appealing to patients and researchers alike
and is expected to be more responsive to interventions for
glaucoma. The GQL-15 has been shown to be strongly
associated with both activity limitation (visual disability) and
various psychophysical tests such as contrast sensitivity, glare
disability, dark adaptation, stereopsis, and Esterman VF score in
Western populations.16 Furthermore, significantly greater
perceived activity limitation among glaucoma patients with
mild VF loss compared with control group was reported in the
same cohort, suggesting that early glaucomatous loss is readily
discernible to patients, which belies the argument that
glaucoma is an asymptomatic condition in its early stages.16
Strong psychometric properties have been reported for the
GQL-15, albeit using the classical test theory (CTT).16
However, the limitations of CTT are well recognized.17,18
Modern test theories, such as item response theory (IRT),
provide several potential advantages over CTT.19–21 For this
reason, the Rasch measurement model, one of the IRT models,
is increasingly used in questionnaire development, and several
legacy questionnaires in ophthalmology, developed using CTT,
have been revalidated.22–24 Recently, the GQL-15 was investi-
gated using Rasch analysis in two glaucoma populations—
German and Singaporean.25,26 The GQL-15 demonstrated
marginally suboptimal psychometric properties in the Singa-
pore population but was still retained in its original form. By
comparison, a revised nine-item version, with superior
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psychometric properties was proposed—the Glaucoma Activ-
ity Limitation-9 (GAL-9)—in the German population.25 As all
the items included in the GQL-15 relate to activity limitation,
the investigators suitably renamed it the GAL. However, neither
of these investigations contained an assessment of validity of
the subscales of the GQL-15.
While considerable literature exists regarding the preva-
lence of different types of glaucoma in India,4,5,7,8 to the best
of our knowledge, there have been no studies to assess the
impact of glaucoma from the patient’s perspective using
glaucoma-specific questionnaires. Given the differences in
literacy rates, socioeconomic status, lifestyle, and the cultural
contexts between developing (such as India) and developed
countries, the results from the latter populations may not be
directly transferable to those in developing countries. Thus,
the aim of the present study was to evaluate the impact of
glaucoma using a glaucoma-specific questionnaire; namely, the
GQL-15. In addition, we determined the relationship between
the severity of VF loss, activity limitation (using GQL-15), and
objective measures (clinical measures of visual function) in this
cohort.
PATIENTS AND METHODS
Participants were recruited during their routine follow-up visit
to the L V Prasad Eye Institute (LVPEI), Hyderabad, India,
between November 2010 and January 2011. Ethics approval
was provided by the Ethics Committee for human research at
the LVPEI and all consenting patients signed an informed
consent form. The study was conducted in accordance with
the tenets of the Declaration of Helsinki.
Participants with established diagnosis of primary glaucoma
who underwent glaucoma evaluation in the past 6 months at
the glaucoma clinic and who had at least two reliable
automated VFs (using Humphrey Automated Field analyzer,
24-2 Swedish Interactive Threshold Algorithm – Standard; Carl
Zeiss Meditec, Inc., Dublin, CA), one of which was performed
in the past 6 months were eligible. Reliable VFs were defined
as those with <20% fixation losses and <33% false-positive and
false-negative response rates. Medical records of all eligible
patients were screened a day prior to their appointment, and
they were invited to participate by either the research
coordinator or the attending glaucoma specialist. A few
potential participants (n¼ 9) refused to participate for various
logistical reasons. Although this number was too small, a
formal analysis revealed that the demographics of these
participants did not substantially differ from those included
in the study. The flow chart (Fig. 1) provides details on the
enrollment of patients.
Patients included in the study were 18 years of age or older;
understood and spoke English, Telugu, or Hindi; and had
POAG, PACG, juvenile open-angle glaucoma, or normal-tension
glaucoma. Given that age-related visually insignificant cataract
(i.e., better eye visual acuity >20/40) has a relatively higher
prevalence in patients with glaucoma, such patients were also
eligible. However, patients with visually significant cataract
(such that the patient had been advised to have surgery in any
eye) were excluded. Glaucoma patients with pseudophakia in
one or both eyes were included. Other criteria for exclusion
were the presence of other impairments (e.g., physical,
cognitive) that could influence their responses, having had
intraocular surgery within the past 3 months, having had laser
therapy within the previous 2 weeks, and the presence of
coexisting ocular morbidity, such as diabetic retinopathy and/
or maculopathy of any etiology.
All the patients underwent a comprehensive clinical
assessment and completed the 15-item GQL. Participants were
provided verbal instructions prior to filling out the GQL-15.
While a little over one-third (65%) self-administered the GQL-
15, trained interviewers administered it to the remaining
FIGURE 1. Study design schema.
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participants. In addition to the administration of the GQL-15,
certain demographic details were also recorded from the
patients, including age, marital status, location of residence,
literacy, occupation, employment status, family history of
glaucoma, systemic comorbidity, and monthly family income
(in Indian Rupees, INR). The following information was
extracted from patients’ medical records: number of years
since first diagnosis of glaucoma, number and type of glaucoma
medications, history of previous glaucoma treatment (surgery
or laser), ocular comorbidity, and VF test results using
automated perimeter. Visual field testing was performed with
appropriate refractive correction, and mean deviation (MD)
was taken as the main global index of severity of VF loss. A VF
was labeled glaucomatous by the glaucoma specialist based on
two reliable threshold-VF examinations of the central 248 or
308 (Swedish interactive threshold algorithm Standard 24-2 or
30-2), if the patient had a glaucoma hemifield test result that
was outside the normal limits or if the pattern SD was flagged
at P < 0.05 on at least two consecutive baseline VF tests.27,28
Additionally, the pattern of VF abnormality had to correspond
with the disc findings for inclusion in the study.
Clinical Assessment
Snellen visual acuity (VA) was recorded monocularly and
converted to logarithm of minimum angle of resolution
(logMAR) for analysis.29 Visual impairment was defined as
presenting VA in better eye <20/60. Monocular contrast
sensitivity (CS) was recorded using the Pelli-Robson contrast
sensitivity chart and a standardized protocol.30
Severity of Visual Field Loss
The severity of VF defects was graded using a standard grading
system: Hodapp–Anderson–Parrish (HAP) grading scale.31–34 In
brief, the MD was used as VF measurement representing
overall VF loss, and the better MD between the two eyes
(better MD) was used to classify the severity of the VF loss.
More important, when viewing binocularly, the better eye will
usually determine the degree of functional impairment.35
Consequently, patients were categorized into three groups of
clinical stages: (1) mild, an MD of no worse than 6 dB; (2)
moderate, an MD of 6 to 12 dB; and (3) severe, an MD worse
than 12 dB. These categories of VF loss were used in the
primary analysis. However, the better MD and the MD of worse
eye (worse MD) were also used as continuous variables during
statistical analysis in the study.
Glaucoma Quality of Life-15 Questionnaire
The GQL-15 consists of 15 items, and these items are grouped
into four subscales: (1) central and near vision (two items); (2)
peripheral vision (six items); (3) dark adaptation and glare (six
items); and (4) and outdoor mobility (one item)16 (Table 1).
Thus, the total number of items across the four subscales is 15.
Participants rate the amount of difficulty in performing a given
activity using five response options ranging from 1 (no
difficulty) to 5 (severe difficulty). An item is coded as ‘‘not
applicable’’ if the participant does not perform the activity
owing to nonvisual reasons. Using standard procedures, local
language versions were obtained using forward–backward
translations of the GQL-15.
Rasch analysis was used to determine whether the total
GQL-15 and subscale scores were valid, reliable, and possessed
measurement characteristics. Subscales were included in the
GQL-15 to provide a comprehensive assessment of activities
that typically affect a glaucoma patient. Furthermore, perfor-
mance of the overall questionnaire cannot ensure adequate
functioning of its subscales, so we investigated the psycho-
metric properties of the each of the subscales of the GQL-15. If
we found flaws in the GQL-15 or its subscales, we attempted to
create reengineered versions of these. Rasch analysis36 was
conducted using the Andrich rating scale model,37 with
Winsteps software (Version 3.68.0; Winsteps, Chicago, IL).38
The Rasch measurement model has been described elegantly
by Massof.39 Four fundamental indicators were used to
evaluate questionnaire quality. These included (1) fit, or the
extent that items in the GQL-15 and its subscales measured a
single construct (i.e., unidimensionality); (2) item difficulty; (3)
targeting, or the extent to which the set of items is of
appropriate difficulty for the level of the participant’s visual
abilities; and (4) measurement precision, using person
separation reliability (PSR; minimum acceptable value 0.80),
or the extent to which the items distinguish distinct levels of
visual functioning in the participants.
Rasch analysis allows estimates of item difficulty (i.e., how
difficult the items are) and person measures (‘‘person ability,’’
representing the extent to which participants or persons
possess the construct being examined) to be made along
postulated constructs; visual functioning in the present case.
Two values are used throughout the analysis: logits (log-odds-
units) and fit statistics (infit mean square). Rasch analysis
estimates measures (interval-level scores) from raw ordinal data
(assigned to response categories), and the unit of Rasch
measurement is logits. In Rasch analysis, both persons
(participants) and items are placed along a hierarchy on this
logit scale. The logit (or log-odds unit) is the natural logarithm
of the odds of a participant being successful at a specific task or
an item being successfully carried out. Conventionally, zero (0)
logit is ascribed to denote item difficulty. For the person
category, logit measures indicate whether one person is more
able than another (e.g., does one person have better visual
functioning than another?). For items, logit measures indicate
whether one item is more difficult than another (e.g., is reading
newspapers more difficult than recognizing faces?). For the
GQL-15 and its subscales, a positive person logit score
indicates more activity limitation (worse visual functioning),
and a positive item logit score indicates a less difficult item.
Conversely, a negative person logit score indicates less activity
limitation (better visual functioning), and a negative item logit
score indicates a more difficult item. In simpler terms, higher
TABLE 1. Item Content of the GQL-15 Questionnaire
Item No. Item Description
1* Reading newspapers
2†‡ Walking after dark
3†‡ Seeing at night
4†§ Walking on uneven ground
5‡ Adjusting to bright lights
6†‡ Adjusting to dim lights
7†‡ Going from light to dark room or vice versa
8†§ Tripping over objects
9†§ Seeing objects coming from the side
10†jj Crossing the road
11†§ Walking on steps/stairs
12§ Bumping into objects
13§ Judging distance of foot to step/curb
14‡ Finding dropped objects
15*† Recognizing faces
* Item belongs to central and near vision subscale.
† Item retained in the revised GQL-15.
‡ Item belongs to glare and dark adaptation subscale.
§ Item belongs to peripheral vision subscale.
jj Item belongs to outdoor mobility.
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positive person scores indicate worse visual functioning,
whereas higher negative person scores indicate better visual
functioning.
Because the Rasch model is probability based, some amount
of deviation of the scores of items can be expected. When an
item does not perform as expected, the fit statistics (i.e., the
infit mean-square statistic) flag the unexpected behavior of an
item. The fit of items to the model was assessed using the fit
statistics, specifically the infit statistic. The ideal value of the
infit mean-square statistic is 1.0, and items with values outside
the range of 0.7 to 1.3 were considered to be misfitting.
However, recent studies suggested that fit statistics alone are
inadequate to determine unidimensionality. Therefore, princi-
pal components analysis (PCA) of the residuals was also used in
combination with Rasch fit statistics to test the unidimension-
ality of the GQL-15 and its subscales. The details of Rasch
analysis have been described elsewhere.23,24
Statistical Analysis
Data analysis was performed with SPSS 16.0 for Windows (SPSS
Inc., Chicago, IL). We used the overall (total) questionnaire
score, linearly estimated using Rasch analysis in univariate and
multivariate regression analysis, and used t-based 95% CI for
the regression coefficients. The purpose of these analyses was
to examine the relationships between self-reported activity
limitation (i.e., questionnaire scores) and demographic and
clinical measures of visual function. All P values were two-
sided and were considered significant when the values were
<0.05. Additionally, independent significant predictors were
considered clinically meaningful if the 95% CI limits of their b
coefficients were either more or less than half the SD of the
mean questionnaire score.40,41
RESULTS
A total of 198 patients responded to the GQL-15 questionnaire
(response rate, 96%). Tables 2 and 3 summarize the sociode-
mographic and clinical characteristics of these participants.
The majority had presenting VA ‡20/30 in the better eye (n¼
162, 82%); only 3% (n¼ 7) were visually impaired (VA <20/60
in better eye). Forty-seven participants (24%) had a worse eye
VA of light perception or no light perception. Participants with
POAG (47%) and PACG (41%) were almost equally distributed
and formed the largest group. Based on better MD, participants
with severe VF loss (39%) comprised the largest group.
Overview of Rasch Analyses of Psychometric
Properties of GQL-15 Questionnaire
Entire GQL-15. There was no evidence of disordered
thresholds, implying that participants used the rating scale was
intended. The PSR was 0.88, which implied acceptable
reliability and established the questionnaire’s ability to
differentiate among at least three distinct strata of participants’
abilities. Targeting was0.96 logits. Two items exhibited misfit
(infit mean square 1.4 and 1.6) and thus were not contributing
towards the measurement of the underlying construct.
Unidimensionality (i.e., if all 15 items measured a single
construct) by PCA of residuals was assessed and revealed that
the unexplained variance by the first contrast was 2.1
eigenvalue units (remaining contrasts were <2.0 eigenvalue
units), indicating a minor departure from unidimensionality
being caused by three items (loading >0.4). Two of these three
items belonged to the peripheral vision subscale and one to
glare and dark adaptation. Two items (‘‘going from light to dark
room or vice versa’’ and ‘‘tripping over objects’’) showed
differential item functioning (DIF), albeit minimal (0.50–1.00
logits), by age group and location. The presence of DIF
indicated that these subgroups do not display the same
probability of endorsing the item. Both of these items were
rated 0.53 and 0.65 logits easier, relative to other items, by
younger participants and urban residents, respectively.
Multidimensionality is critical to measurement because in its
absence, the user cannot be certain of the nature of the
construct under measurement. In order to optimize its
measurement properties, it was essential that the questionnaire
be segregated into several unidimensional constructs. The first
dimension contained items from the peripheral vision domain;
the second dimension contained glare and dark adaptation
items.
The way forward to restore unidimensionality in the GQL-
15 was to delete the three multidimensionality-causing items;
once deleted, the remaining 12 items constituted a unidimen-
sional measure. However, two items misfit (infit mean square
1.4 and 1.5) and were deleted iteratively. Consequently, the
revised 10-item questionnaire was unidimensional, consisting
of items that all fit the Rasch model (Table 1). The PSR was
0.86,which implied acceptable reliability and established the
revised questionnaire’s ability to differentiate between at least
three distinct strata of participants’ activity limitations. By
comparison, the PSR of the GQL-15 was 0.88, indicating that
the shortening to 10 items did not affect its reliability. More
important, the 10-item scale consisted of items that all
measured the same construct, so the use of a summary or
total questionnaire score is valid. The underlying construct of
the 10 items is vision-related activity limitation rather than
quality of life (QOL), so we renamed the revised version the
Glaucoma Activity Limitation-10 or GAL-10 (Table 1). Similar
suggestions have been made by previous investigators in favor
of renaming the revised Rasch version of the GQL-15 to GAL-
9.25
Hence, for the remainder of this article, we refer to the
reengineered version of the GQL-15 as the GAL-10, and we
present all our analyses related to this version. The GAL-10
score has interval level properties, implying that it is
appropriate for use in parametric statistics in further analyses.
Figure 2 is a histogram of the GAL-10 person scores in logits (P
¼ 0.03, Kolmogorov–Smirnov test). Lower scores represent
better visual functioning (i.e., reduced activity limitation). The
mean (6SD) overall glaucoma participants’ GAL-10 score was
0.81 (61.33) logits, indicating that the revised 10 items in the
GAL were reasonably matched to the participants’ activity
limitations (Fig. 3). Furthermore, the negative value for the
mean score indicates that overall the participants had good
glaucoma-specific visual functioning. The three most difficult
activities reported included ‘‘walking after dark,’’ ‘‘seeing at
night,’’ and ‘‘walking on uneven ground.’’ The three least
difficult activities were ‘‘adjusting to dim light,’’ ‘‘tripping over
objects,’’ and ‘‘recognizing faces.’’ Considering that the SD of
the mean GAL-10 score was 1.33 logits, significant indepen-
dent predictors were also deemed to be clinically significant if
the CI limits of their b coefficients were greater than 0.66 or
less than 0.66. These two values are approximately half the
SD of the mean, which is generally considered to be a useful
estimate of a clinically meaningful difference.
Although the underlying construct is activity limitation in
the GAL-10 (present study) as well as in the GAL-9 proposed by
Khadka et al.,25 and both have been demonstrated to possess
superior psychometric properties as compared with the
original GQL-15 in the population assessed, there is a minor
difference: the GAL-10 has 10 items, whereas there are nine in
the GAL-9. Nonetheless, the two versions share seven common
items. Furthermore, the items in the GAL-10 were better
targeted to participant ability than those in the GAL-9.
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However, targeting is sample dependent, so it is possible that
GQL-9 may have performed differently in our population and
vice versa.
Subscales. Of the four subscales, the three multi-item
subscales were analyzed using Rasch analysis. Only a single
subscale, ‘‘peripheral vision,’’ was found to meet the require-
ments of the Rasch measurement model. The PSR was 0.80,
and all the items fit the Rasch model well (infit mean square,
0.84–1.17). PCA of residuals indicated unidimensionality
(unexplained variance by first contrast was 1.6 eigenvalue
units). The mean (6SD) overall participants’ peripheral vision
score was 1.02 (61.47) logits, indicating slight mistargeting.
That is, the participants had a lower activity limitation (better
peripheral vision functioning) than what could be captured by
the items. However, this subscale could not be retained in its
entirety in GAL-10, so there is no role for subscales in the
revised 10-item questionnaire (GAL-10). The remaining two
subscales (‘‘central and near vision’’ and ‘‘glare and dark
adaptation’’) had PSR values significantly below the minimum
accepted value of 0.80. Given that these subscales lacked the
fundamental requirement of measurement precision, these
were considered dysfunctional and were not analyzed further.
Relationship between Activity Limitation and
Sociodemographic Characteristics, and Severity of
Visual Field Loss from Glaucoma
Univariate analysis (Table 3) demonstrated that rural dwellers
and those whose monthly family income ranged from 5000 to
10,000 INR per month reported significantly greater activity
limitation on the GAL-10 (P < 0.05). Participants did not vary
in their GAL-10 scores by other sociodemographic variables
assessed.
We examined the data to determine if increments of VF loss
(severity of glaucoma) were associated with a corresponding
increase in activity limitation (i.e., if there was a dose–response
relationship between the severity of VF loss and the GAL
score). Table 4 displays this relationship. In each case,
TABLE 2. Sociodemographic and Clinical Characteristics of the Participants Who Responded to the GQL-15 Questionnaire (n¼ 198)
Participant Characteristic Result
Mean age, y 6 SD 59.8 6 12.34




Mean duration of glaucoma, y 6 SD 8.0 6 6.8
Range, y 8 mo to 58 y
Work status, n (%)
Working 66 (33)
Not working 132 (67)
Retired 77 (39)
Homemaker 49 (25)
Visual reasons 6 (3)
Presenting VA in the better eye, mean 6 SD
LogMAR (Snellen) 0.15 6 0.18 (20/32þ2)
Range
LogMAR (Snellen) 0.0 to 0.9 (20/20 to 20/160)
Median logMAR (Snellen) 0.10 (20/25)
Presenting VA in the worse eye, mean 6 SD
LogMAR (Snellen) 0.74 6 0.86 (20/125þ3)
Range
LogMAR (Snellen) 0.0 to 2.5 (20/20 to no LP)
Median logMAR (Snellen) 0.30 (20/40)
Presenting Pelli-Robson CS in the better eye, LogCS
Mean 6 SD 1.12 6 0.27
Range 0.15 to 1.50
Presenting Pelli-Robson CS in the worse eye, LogCS
Mean 6 SD 0.96 6 0.40
Range 0.0 to 1.50




Better MD score, dB
Mean 6 SD 12.03 6 9.35
Range 0.38 to 32.44
Median 8.68
Worse MD score, dB
Mean 6 SD 19.37 6 8.30
Range 6.11 to 33.02
Median 19.01
LP, light perception.
* Based on better mean deviation (using Humphrey Field Analyzer program 24-2).
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TABLE 3. Summary (Logit) Scores of GAL-10 Questionnaire (i.e., Revised Version of GQL-15) Stratified by Participant Characteristics (n¼ 198)
Participant Characteristic No. (%)
Glaucoma Activity Limitation-10
Summary Logit Score* (Mean 6 SD)
All subjects
Mean 6 SD (range) 198 (100) 0.81 6 1.33 (3.71–2.41)
Median age, y
<61 96 (48) 1.37 6 1.94
‡61 102 (52) 1.20 6 1.71
Sex
Male 132 (67) 1.16 6 1.81
Female 66 (33) 1.54 6 1.83
Area
Urban 167 (84) 1.45 6 1.82†
Rural 31 (16) 0.38 6 1.53
Median duration of glaucoma, y‡
<6.5 97 (50) 1.35 6 1.63
‡6.5 97 (50) 1.26 6 1.98
Marital status
Not married 6 (3) 1.31 6 1.40
Married 176 (89) 1.25 6 1.82
Widowed 16 (8) 1.68 6 1.98
Level of education
No formal education 20 (11) 1.17 6 2.04
Primary school 71 (38) 1.14 6 1.66
Secondary school 77 (42) 1.59 6 1.88
Higher degree 16 (9) 1.25 6 1.91
Work status
Working 66 (33) 1.37 6 1.79
Not working 132 (67) 1.25 6 1.84
Monthly income (Indian rupees)‡
<5000 23 (12) 1.00 6 1.60
5000 to 10,000 33 (17) 0.48 6 1.80§
>10,000 138 (71) 1.48 6 1.81
Systemic Comorbidityjj
Absent 93 (47) 1.37 6 1.92
Present 104 (53) 1.19 6 1.73
Family history of glaucoma‡
Yes 39 (20) 1.17 6 2.03
No 159 (80) 1.31 6 1.77
Type of glaucoma
POAG 94 (48) 1.55 6 1.93
PACG 82 (41) 0.98 6 1.61
Juvenile open-angle glaucoma 12 (6) 1.68 6 2.33
Normal tension glaucoma 10 (5) 0.81 6 1.42
Glaucoma treatment category‡
Laser alone 2 (1) 2.76 6 3.06
Pharmacologic therapy alone 67 (34) 1.62 6 1.81
Surgery alone 14 (7) 1.00 6 1.42
Combination therapy (medical & surgery/
medical & laser/surgical and laser)
114 (58) 1.09 6 1.84
Number of glaucoma medications¶
1 94 (54) 1.43 6 1.88
>1 79 (46) 1.14 6 1.81
Lens status
Pseudophakia
1 eye 33 (17) 1.09 6 1.91
Both eyes 26 (13) 1.19 6 2.16
Cataract
None 23 (12) 2.05 6 1.97
1 eye 9 (5) 0.88 6 2.05
Both eyes 103 (53) 1.27 6 1.63
* GAL-10 questionnaire (revised GQL-15 using Rasch analysis); higher negative values for GAL-10 summary logit score indicate lower activity
limitation.
† Denotes a significant statistical difference between the mean GAL-10 overall scores across the categories for that characteristic (P < 0.05).
‡ Data not available for a few patients (ranging from 1–15).
§ A significant difference between the GAL-10 scores of participants whose monthly income ranged between 5000 and 10,000 as compared
with those whose income was >10,000 Indian Rupees (P < 0.05).
jj Includes diabetes, hypertension, coronary artery disease, and asthma.
¶ Twenty-five patients did not require any medications for glaucoma.
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univariate analysis revealed a significant reduction in the score
(i.e., increased activity limitation) with worsening glaucoma
levels. Participants with mild VF loss had significantly better
glaucoma-specific visual functioning as compared with those
with moderate or severe VF loss. Participants with severe VF
loss had reductions in GAL-10 score of 72% (95% CI, 64.7–
79.3) and 61% (95% CI, 52.6–69.4) when compared with those
with mild and moderate VF loss, respectively (Table 4).
However, there was no difference in functioning between
those with mild and moderate VF loss using the GAL-10 (P ¼
0.07).
In the multivariate model, after controlling for potential
confounders, only income and severity of VF loss remained
independently associated with glaucoma-specific visual func-
tioning using the GAL-10. Compared with patients with higher
monthly income, those in the middle-income group had
significantly poorer functioning (b ¼ 0.84; 95% CI, 0.16–1.52;
P ¼ 0.02). Also, compared with patients with mild VF loss,
those with severe VF loss had significantly poorer visual
functioning (b ¼ 1.19; 95% CI, 0.61–1.78; P < 0.0001).
However, none of these independent associations were
clinically significant.
Relationship between Activity Limitation and
Clinical Measures of Visual Function in Glaucoma
All of the clinical measures of visual function (visual acuity,
contrast sensitivity, and mean deviation) demonstrated signif-
icant, albeit moderate correlations (r ¼ 0.36–0.49) with the
GAL-10 score (Table 5). However, considerable scatter was
observed in the correlations, and an example of such scatter
for better MD is depicted in Figure 4. Given the results from
previous studies, we expected to find higher correlations
between activity limitation (GAL-10 scores) and clinical
measures of visual function of better eye, compared with
those of worse eye. We found the GAL-10 scores to be
statistically significantly correlated with the clinical measures
and of similar magnitude for both better and worse eye.
Conversion of Raw to Rasch-Scaled Scores
The results of the present study are likely to be generalizable to
other populations, but population samples vary, so it is always
best to implement Rasch measurement properties by actually
performing Rasch analysis. However, other investigators may
wish to use the GAL-10 and also gain the interval-scoring
benefits of Rasch analysis without performing Rasch analysis
themselves. For the benefit of such investigators, we have
developed a series of Excel (Microsoft, Redmond, WA)
spreadsheets, which convert raw (ordinal) GAL-10 scores to
Rasch measurement estimates. These spreadsheets can be
obtained by contacting the corresponding author.
DISCUSSION
This cross-sectional study from a South Indian glaucoma
population demonstrates a consistent pattern of worsening
of functioning (poorer GAL-10 scores) with increasing amounts
of VF loss across the disease spectrum. This is consistent with
outcomes reported by similar such studies in the Western
glaucoma populations.16,42–44 Patients with severe VF loss
reported significantly worse functioning due to glaucoma.
However, those with mild and moderate VF loss also reported
functioning difficulties, providing evidence of the impact of VF
loss and of a dose–response relationship: increasing severity of
VF loss in the eye with better MD was associated consistently
and independently with increasing activity limitation (i.e.,
lower negative logit scores on the GAL-10). Participants with
severe VF loss had reductions in GAL-10 score of 72% (as
compared with mild VF loss) and 61% (as compared with
moderate VF loss). These findings are consistent with those of
Nelson et al. who developed and used the GQL-15.16
Our results are in accordance with those from developed
countries that have demonstrated the deleterious effects of VF
loss on vision-specific functioning in glaucoma.16,43–48 For
example, the population-based Los Angeles Latino Eye Study
(LALES) used the National Eye Institute-Visual Function
Questionnaire (NEI-VFQ) and reported that greater VF loss in
patients with OAG impacts on the vision-related QOL.47 Parrish
et al. demonstrated that perceived difficulty with driving
increases with worsening VF damage in the better eye of
glaucoma patients.49 Using the same GQL-15 as in the present
study, Goldberg et al. reported that the GQL-15 scores differ
significantly among patients with mild, moderate, and severe
glaucoma, demonstrating a trend of poorer functioning with
increasing severity in an Australian clinic-based sample.44 In a
recent study of a Singapore hospital-based glaucoma sample
that also used the GQL-15, Wang et al. demonstrated a
significant and independent association between the severity
of bilateral glaucoma and functioning.26 They reported that the
deterioration in functioning is clinically significantly worse in
those with bilateral moderate/severe glaucoma. Taken togeth-
er, these findings suggest that glaucoma impacts functioning
transcending all barriers such as ethnicity, race, and culture.
Until now, all four studies that used the GQL-15 had been
conducted in Western populations (United Kingdom, Australia,
Germany, and Singapore).16,25,26,44 Two of the four studies
used the raw (Likert) scores from the GQL-15, but the recent
two studies in the German and Singaporean populations have
performed Rasch analysis of the GQL-15. Our results of the
GAL-10 are unique given that there is a lack of literature
regarding the use of glaucoma-specific questionnaires such as
the GQL-15 from India.
While other studies have reported variables such as age44
and a history of surgery for glaucoma to be related to visual
functioning,50 we failed to find such associations. In our study,
FIGURE 2. Histogram showing distribution of person scores using
Rasch analysis of the GAL-10 questionnaire estimated from partici-
pants’ ratings of the difficulty of 10 items. Person scores are expressed
in logits. A positive person logit score indicates greater activity
limitation (worse function), whereas a negative person logit score
indicates lower activity limitation (better function).
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the median duration since diagnosis of glaucoma was 6.5 years,
and 58% were on combination therapy for glaucoma, so it is
unlikely that our participants were unaware of their diagnosis/
status of glaucoma (although this information was not
collected by us). Nonetheless, the knowledge of the diagnosis
and information about the status of glaucoma in patients under
periodic follow-up could potentially influence their responses
to items on the GAL-10.51 The mean GAL-10 score in the
present study was 0.81 6 1.33 logits, indicating that our
participants did experience activity limitation regardless of the
duration of glaucoma. Therefore, the knowledge or history of
glaucoma would have had a negligible impact (if any in terms
FIGURE 3. Person item map of the GAL-10 questionnaire. Left of the dashed line: participants represented by ‘‘x.’’ Right of the dashed line: items
denoted by their content. Top of the map: participants with lower ability and least difficult items. On the whole, the item difficulty matches the
ability of the participants, which is represented by the x’s being concentrated where the items are located and the means of the two distributions,
denoted by M, being close to each other. Each ‘‘x’’ and ‘‘.’’ represent two and one participant, respectively. M, mean; S, 1 SD from the mean; T, 2 SD
from the mean.
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of underreporting) on the responses to the GQL-15. Our belief
is further supported by the LALES, which comprised 75%
newly diagnosed glaucoma patients and 25% patients with a
history of glaucoma, who were found to have differences in
QOL scores (using NEI-VFQ and Short-form 12 [SF-12]) by VF
loss status despite adjusting or excluding those with history of
glaucoma and/or treatment history from the analyses.47 In the
present study, using multivariate analysis, we found that
patients in the middle-income group reported statistically
worse functioning than those in the higher income group; this
was not clinically significant. This finding is perhaps not
surprising given their socioeconomic status; patients in the
middle-income group could have had an advanced stage of the
disease at presentation and may have lacked compliance and
adherence to medications resulting in uncontrolled intraocular
pressures. Other variables not included in our study, such as
psychological factors (presence of depression, mood state,
anxiety) and family support systems, could all have hypothet-
ically affected responses to the GQL-15. These factors require
investigation in future studies.
As mentioned in the Results section, other investigators
who wish to use the GAL-10 can use either the Excel
spreadsheets developed by us to obtain the interval-level
scores for their raw data (if their sample is similar to that of
present study) or perform Rasch analysis on their own data. In
the latter case, it is likely that a new study of GQL-15 in a
different population could result in another Rasch version of
the questionnaire.
A number of studies that have used questionnaires have
revealed aspects of vision that most influence patients’ beliefs
about their vision.16,43,45,47,49,51–54 However, the relationship
between vision and performance of daily activities is much
more complex than can be gleaned from questionnaires on
self-reported functioning. Aspects of vision include the ability
to detect motion, recognize patterns (acuity), distinguish
borders (contrast sensitivity), appreciate color, and notice
objects in different parts of the VF.55 Given the results of
previous studies using questionnaires in glaucoma patients,
some correlation between clinical measures of vision and the
GAL-10 score would be expected in our sample. The
relationship between activity limitation and all clinical
measures of vision used in the present study was equally
strong. Nonetheless, the role of contrast sensitivity—the not-
so-commonly recorded clinical measure—deserves mention.
We found VA and contrast sensitivity to be moderately
correlated with each other (r ¼ 0.63, P < 0.0001).
Correlations in the range of 0.5 to 0.6 with VA have been
reported previously,56 so our findings are as expected. This
relationship perhaps suggests that contrast sensitivity is less
likely to provide any new information at higher spatial
frequencies as has also been demonstrated in the work by
Elliott and Hurst.57 However, Pelli-Robson contrast sensitivity
provides information concerning low to medium spatial
frequencies only, and this is the region that is most closely
associated with activity limitation in glaucoma patients for
tasks such as reading, face recognition, and mobility.16
Therefore, in accordance with other investigators,58,59 we
believe that the Pelli-Robson contrast sensitivity test is likely to
provide important information about the difficulties faced by
glaucoma patients in performing daily activities, especially in
those with near-normal VA.
While the pattern of these correlations was in the expected
direction, all of these relationships possessed considerable
scatter (Fig. 4), which also appears to be consistent with
several earlier studies.16,43,60–63 In addition, the correlations
were not significantly different in the better or worse eye for
any of the clinical measures of vision. Other studies have also
reported a lack of distinct difference in the correlation of visual
functions of better or worse eye with self-reported visual
functioning.42,43,45 In our study, the worse eye acuity followed
by better MD showed the strongest correlation with the GAL-
10 score. This finding is similar to that by Jampel et al., albeit
using a different questionnaire, the NEI-VFQ, in an American
population.60 As proposed by Jampel et al., the reason that
worse eye acuity and better MD relate more closely to patient’s
perspective could be due to the difference in the psychophys-
ical measurement of VA and VF, which reveals aspects of inter-
eye performance that differ from VF testing.60
The use of questionnaires in the assessment of activity
limitation has pitfalls because they are, by their nature,
subjective and are affected by various factors; for example,
culture, language, education, social desirability, and so
forth.64–66 These nonvisual variables could be the reason for
the scatter observed in patients’ responses to questionnaires.
Given the limitations of questionnaires, performance-based
measures (PBMs), which involve testing what a person can
TABLE 4. Relationship between Severity of Visual Field Loss and the GAL-10 Questionnaire Score
Category of VF Loss* GAL-10 Score (Mean 6 SD, Range)† Visual Performance (%)‡ P Value§
Mild 1.98 6 1.82 (4.93 to 0.82) – –
Moderate 1.43 6 1.66 (4.93 to 1.91) 28%  (vs. mild) 0.253
Severe 0.56 6 1.67 (4.93 to 2.41) 72%  (vs. mild) <0.0001
61%  (vs. moderate) 0.014
* Mean deviation of better eye used for classification (mild VF loss – mean deviation no worse than 6 dB in better eye; moderate VF loss – mean
deviation between 6 and 12 dB in better eye; severe VF loss – mean deviation worse than 12 dB in better eye).
† GAL-10 score (in logits); higher negative values indicate better score and lower activity limitation.
‡ Visual performance compared for moderate and severe VF loss categories against mild.
§ Using ANOVA with post-hoc analysis (Tukey); P < 0.05 indicates statistically significant.
TABLE 5. Spearman Rank Correlation for the GAL-10 Questionnaire Overall Score with Clinical Measures of Visual Function*
Questionnaire
VA Pelli- Robson CS Perimetric MD
Better Eye Worse Eye Better Eye Worse Eye Better Eye Worse Eye
GAL-10† 0.35 0.49 0.38 0.36 0.40 0.35
* P < 0.0001 for association with all clinical measures.
† GAL-10 - revised version using Rasch analysis of the Glaucoma Quality of Life-15 questionnaire.
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and cannot do by actually observing the person attempting to
perform specified tasks, have received increased attention.67–
69 Assessment of disability related to vision is one such PBM
that has been developed recently in ophthalmology and has
been shown to be a valid and reproducible method for
assessing glaucoma patients.61,68
The strengths of our study are the relatively large sample
size and the inclusion of participants with mild to severe VF
loss. The use of a glaucoma-specific questionnaire and Rasch
analysis to validate it, so as to produce an estimated linear
interval overall measure of activity limitation, is another
significant strength of this study. To our knowledge, this is
the first time that GQL-15 and its subscales have been
subjected to Rasch analysis in a South Indian glaucoma
population, and it has resulted in a valid unidimensional
measure of activity limitation (GAL-10) in these patients.
However, our study has some limitations. There was a male
preponderance (67%), a higher proportion were literates
(89%), and the majority were from urban areas (84%); however,
this was perhaps expected given the tertiary eye care centre–
based sample, so our sample may not be fully representative of
the population, and the results cannot be generalized to
glaucoma patients in a community setting. Furthermore, the
cross-sectional design of our study has to be considered while
interpreting the reduction in glaucoma functioning (GAL-10
scores) across subgroups of participants. The reduced scores
are based on comparison between participants categorized
into different groups and do not necessarily indicate a
longitudinal shift in the activity limitation with a change in
the VA or VF or the status of glaucoma. We studied the VA, CS,
and VF in better and worse eye separately, but not binocularly.
One could argue for the need to include binocular data. We did
not explore the potential effects of loss of color vision and
other psychophysical measures, including disability glare, dark
adaptation, and stereopsis on activity limitation. These
psychophysical measures have been reported to be compro-
mised in glaucoma.16 The potential effects of these measures
on activity limitation need further exploration in futures
studies.
In conclusion, our study provided evidence of the impact of
glaucoma on visual functioning (activity limitation) as mea-
sured by GAL-10 in glaucoma patients. With superior
measurement properties, the GAL-10 can be used in place of
the original GQL-15 as a summary index of activity limitation
for glaucoma patients, and its brevity may make clinical
application simpler. By using Rasch analysis to generate an
overall score with interval characteristics for the GAL-10, our
data showed a dose-related gradient relationship between the
severity of VF loss and activity limitation in a South Indian
glaucoma population. Nonetheless, the limitations of question-
naires, including the GAL-10, in the assessment of activity
limitation should be considered when interpreting the results.
Given the potential advantages of PBMs of visual function, for
example, the Assessment of Disability Related to Vision
(ADREV) PBMs are likely to play an important role in the
assessment of impact of glaucoma on patients. Nonetheless,
PBMs have only recently been introduced in ophthalmology,
and their relationship with questionnaires and clinical mea-
sures of vision is still being studied. Until PBMs gain wide
acceptance, the results of studies using reliable and valid
questionnaires, such as the GAL-10 in our study, would offer
clinicians a reasonably good understanding of activity limita-
tion from the glaucoma patient’s perspective and serve as a
guide in referral to low vision rehabilitation services at the
appropriate time.
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